Literature DB >> 1954223

Inhibition of rat renal 11 beta-hydroxysteroid dehydrogenase by steroidal compounds and triterpenoids; structure/function relationship.

H Bühler1, F H Perschel, K Hierholzer.   

Abstract

Various compounds with steroidal structure were tested for inhibitory effects on enzymatic activity of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) from rat renal microsomes. Most substances exerting inhibitory potency on both the oxidative as well as the reductive activity can be classified into two main groups: pentacyclic triterpenoids of the oleane type and steroidal detergents of the CHAPS-series. Inhibition is competitive, as was shown for one compound of each group. The IC50 values of the various inhibitors range over five orders of magnitude. In all cases, oxidative activity was inhibited more effectively than reductive activity. An attempt has been made to correlate structural properties and inhibitory potency. In brief, inhibition seems to be enhanced by a C11-oxygen function, which is present in all endogenous glucocorticosteroids and a C7-OH function. Inhibition is reduced by a large and polar substituent at C3 in the A-ring. A large D-ring substituent, such as a bisgluconamidopropyl side chain or even an additional E-ring, does not prevent binding to the enzyme, although inhibition seems to be influenced by its steric conformation. The cardiac glycosides and steroidal antibiotics tested exert no inhibitory effect on 11 beta-HSD. Cholesterol and pentacyclic triterpenoids of the lupane type exhibit a very poor inhibition, probably caused by the localization of planar structures in the ring systems, which differs from that of the effective oleane type inhibitors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954223     DOI: 10.1016/0304-4165(91)90268-l

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives.

Authors:  Li Huang; Donglei Yu; Phong Ho; Keduo Qian; Kuo-Hsiung Lee; Chin-Ho Chen
Journal:  Bioorg Med Chem       Date:  2008-06-05       Impact factor: 3.641

2.  Development of a high-throughput cell-based assay for 11beta-hydroxysteroid dehydrogenase type 1 using BacMam technology.

Authors:  Da-Yuan Wang; Quinn Lu; Stacey L Walsh; Lisa Payne; Sundip S Modha; Martin J Scott; Thomas D Sweitzer; Robert S Ames; Daniel J Krosky; Hu Li
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

Review 3.  Inhibitors of connexin and pannexin channels as potential therapeutics.

Authors:  Joost Willebrords; Michaël Maes; Sara Crespo Yanguas; Mathieu Vinken
Journal:  Pharmacol Ther       Date:  2017-07-15       Impact factor: 12.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.